ProfileGDS4718 / 1555159_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 8% 10% 6% 7% 11% 8% 11% 7% 13% 11% 16% 3% 7% 3% 9% 7% 8% 9% 6% 4% 9% 12% 8% 9% 9% 10% 14% 7% 8% 11% 6% 11% 12% 6% 9% 7% 12% 10% 8% 9% 8% 9% 7% 9% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.72538
GSM549102patient 115, normal, homogenized [OPG study]3.7884810
GSM549104patient 119, normal, homogenized [OPG study]3.58516
GSM549108patient 138, normal, homogenized [OPG study]3.672517
GSM549119patient 077, normal, homogenized [OPG study]3.806111
GSM549133patient 032, cancer, homogenized [OPG study]3.665398
GSM549139patient 042, cancer, homogenized [OPG study]3.7913611
GSM549099patient 107, normal, homogenized [OPG study]3.680057
GSM549109patient 139, normal, homogenized [OPG study]3.9243313
GSM549110patient 046, normal, homogenized [OPG study]3.8284311
GSM549114patient 063, normal, homogenized [OPG study]3.9869616
GSM549122patient 082, normal, homogenized [OPG study]3.513263
GSM549134patient 033, cancer, homogenized [OPG study]3.658997
GSM549136patient 036, cancer, homogenized [OPG study]3.451413
GSM549140patient 044, cancer, homogenized [OPG study]3.722799
GSM549111patient 047, normal, homogenized [OPG study]3.652927
GSM549113patient 057, normal, homogenized [OPG study]3.663288
GSM549132patient 031, cancer, homogenized [OPG study]3.722579
GSM549137patient 038, cancer, homogenized [OPG study]3.629726
GSM549142patient 047, cancer, homogenized [OPG study]3.596414
GSM549100patient 110, normal, homogenized [OPG study]3.728619
GSM549107patient 135, normal, homogenized [OPG study]3.8380212
GSM549115patient 068, normal, homogenized [OPG study]3.680128
GSM549116patient 072, normal, homogenized [OPG study]3.748189
GSM549120patient 078, normal, homogenized [OPG study]3.736899
GSM549131patient 030, cancer, homogenized [OPG study]3.73910
GSM549118patient 074, normal, homogenized [OPG study]3.9247914
GSM549129patient 027, cancer, homogenized [OPG study]3.69197
GSM549123patient 088, normal, homogenized [OPG study]3.708888
GSM549124patient 006, cancer, homogenized [OPG study]3.8368311
GSM549126patient 015, cancer, homogenized [OPG study]3.590786
GSM549128patient 025, cancer, homogenized [OPG study]3.7793611
GSM549103patient 117, normal, homogenized [OPG study]3.8919112
GSM549117patient 073, normal, homogenized [OPG study]3.643346
GSM549138patient 041, cancer, homogenized [OPG study]3.710319
GSM549141patient 045, cancer, homogenized [OPG study]3.622187
GSM549130patient 028, cancer, homogenized [OPG study]3.8608712
GSM549101patient 111, normal, homogenized [OPG study]3.7877910
GSM549105patient 128, normal, homogenized [OPG study]3.700018
GSM549106patient 134, normal, homogenized [OPG study]3.692619
GSM549112patient 048, normal, homogenized [OPG study]3.702198
GSM549125patient 011, cancer, homogenized [OPG study]3.752749
GSM549127patient 024, cancer, homogenized [OPG study]3.636327
GSM549135patient 035, cancer, homogenized [OPG study]3.698659